Back to News
Market Impact: 0.2
State Street SPDR S&P Biotech ETF Experiences Big Outflow
Source: Nasdaq
Healthcare & BiotechMarket Technicals & FlowsInvestor Sentiment & Positioning
State Street SPDR S&P Biotech ETF (XBI) recorded approximately $184.3 million in weekly outflows, reducing shares outstanding by 1.7%. The redemption activity signals modestly weaker investor positioning toward the biotech sector, though the reported flow is unlikely to have broad market implications.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
More News
- From Wall Street to Silicon Valley, Anthropic IPO poised to have massive 'trickle-down effect'
- Anthropic’s IPO filing shows explosive growth, risks and staggering costs
- Lula wins Brazil runoff after prediction markets favored Bolsonaro
- Brazil’s real sinks after Lula’s re-election victory
- One-Day Wipeout Tops 60% For the Hardest-Hit Brazilian Stocks
- MSCI Fallout Widens With Indonesian Corporate Bond Sale Shelved